Tackling Malaria and Vectorborne Diseases in India

Malaria remains one of the most significant public health challenges in India, despite decades of sustained control efforts. Caused by Plasmodium parasites and transmitted through the bite of infected female Anopheles mosquitoes, this disease affects millions of people each year, particularly in rural and tribal areas. Understanding its transmission, clinical presentation, and the evolution of national control programmes is essential for healthcare professionals working in community health settings.

Understanding malaria: the causative agent and transmission 🔗

Malaria is caused by protozoa of the genus Plasmodium, with four species commonly infecting humans: Plasmodium falciparum, P. vivax, P. malariae, and P. ovale. Of these, P. falciparum causes the most severe and potentially fatal form of the disease, while P. vivax is the most widespread species in India.

The transmission cycle begins when an infected female Anopheles mosquito bites a human and injects sporozoites along with saliva into the bloodstream. These sporozoites rapidly invade liver cells within about 30 minutes of inoculation, where they multiply extensively. After the liver phase, merozoites are released into the bloodstream and invade red blood cells, causing the characteristic symptoms of malaria.

In India, nine Anopheline vector species are involved in transmitting malaria across diverse geographical settings. The mosquitoes typically feed from dusk to dawn, making nighttime the highest-risk period for transmission.

Clinical presentation: the classic malaria paroxysm 🔗

The hallmark of malaria is fever, often accompanied by chills, headache, muscle pain, nausea, and vomiting. As the disease progresses, some patients develop the classic malaria paroxysm with distinct stages that cycle predictably based on the parasite species involved.

The cold stage 🔗

This first stage lasts approximately 15 to 60 minutes and is characterised by intense shivering and a feeling of extreme cold. Patients experience bed-shaking chills, and their teeth may chatter. Despite covering themselves with blankets, they cannot get warm. The skin becomes cold, dry, and pale due to peripheral vasoconstriction.

The hot stage 🔗

The hot stage follows and lasts 2 to 6 hours, during which fever may reach 41°C. Patients experience flushed, dry skin, intense headache, nausea, and vomiting. This stage occurs because the body has reached the elevated temperature set point triggered by the immune response to parasite material released from ruptured red blood cells.

The sweating stage 🔗

The final stage lasts 2 to 4 hours, during which the fever drops rapidly and the patient sweats profusely. Body temperature returns to normal, and symptoms subside, leaving the patient exhausted but relatively well until the next cycle begins.

Fever periodicity and incubation 🔗

The timing of these paroxysms depends on the Plasmodium species. In P. vivax and P. ovale infections, fever occurs every 48 hours (tertian malaria), while P. malariae causes fever every 72 hours (quartan malaria). P. falciparum fever is often irregular without distinct periodicity.

The incubation period-the time between mosquito bite and symptom onset-varies by species. For P. falciparum, the average incubation period is 11 days, ranging from 9 to 30 days. P. vivax typically has an incubation period of 8-14 days, though dormant liver forms (hypnozoites) can cause relapses months or years later.

The burden of malaria in India 🔗

At the time of independence in 1947, malaria was one of India’s most pressing public health challenges, with an estimated 75 million cases annually and 800,000 deaths. The disease affected approximately 22% of the population and caused tremendous economic burden, particularly in agricultural communities.

About 95% of India’s population resides in malaria-endemic areas, with approximately 80% of reported cases confined to tribal, hilly, and inaccessible regions comprising just 20% of the population. States like Odisha, Chhattisgarh, Jharkhand, and the northeastern states have historically borne the highest disease burden.

Evolution of national malaria control programmes 🔗

National Malaria Control Programme (1953) 🔗

The National Malaria Control Programme (NMCP) was launched in 1953, built around three key strategies: indoor residual spraying (IRS) with DDT, monitoring and surveillance of cases, and treatment of patients. This comprehensive approach produced rapid results, dramatically reducing malaria-related morbidity and mortality within a few years.

National Malaria Eradication Programme (1958) 🔗

India launched its National Malaria Eradication Programme (NMEP) in 1958, aiming to completely interrupt transmission through residual insecticide spraying combined with chemotherapy and anti-larval methods in urban areas. The strategy produced spectacular results-by 1965, malaria was reduced from around 75 million cases annually to about 100,000 cases per year.

By 1964, malaria had been eradicated from 88% of the country, with advanced spraying operations continuing in remaining areas. This remarkable achievement demonstrated the potential for effective disease control through coordinated public health interventions.

The resurgence crisis 🔗

Unfortunately, success proved difficult to sustain. In 1976, there was a massive resurgence of malaria with 6.46 million cases reported. This dramatic reversal was attributed to poor health infrastructure, sub-optimal monitoring and logistics, DDT shortages, and the emergence of both parasite resistance to chloroquine and vector resistance to insecticides.

Modified Plan of Operation (1977) 🔗

The Modified Plan of Operation (MPO) was launched in 1977 with a three-pronged strategy: early diagnosis and prompt treatment, vector control, and Information Education Communication (IEC) with community participation. Malaria incidence declined again, and by 1984, cases were reduced to about 2 million with 247 deaths.

Integration into NVBDCP 🔗

In 2002, the malaria control programme was integrated with other vector-borne disease programmes under the National Vector Borne Disease Control Programme (NVBDCP). This integrated approach addresses malaria along with dengue, lymphatic filariasis, kala-azar, Japanese encephalitis, and chikungunya. New tools were introduced including rapid diagnostic tests (RDTs), artemisinin-based combination therapy (ACT), and long-lasting insecticidal nets (LLINs).

Current progress and elimination targets 🔗

Malaria cases and deaths have dropped by approximately 80% from 2015 to 2023, with cases declining from 1,169,261 to 227,564 and deaths falling from 384 to just 83. India has exited the WHO’s High Burden to High Impact group in 2024, marking a significant milestone in its elimination journey.

The National Framework for Malaria Elimination (NFME), launched in 2016, provides a roadmap for achieving zero indigenous cases by 2027. The government has set an ambitious target to eliminate malaria completely by 2030. As of 2023, 122 districts across various states reported zero malaria cases, demonstrating the effectiveness of targeted interventions.

Prevention and control strategies 🔗

Personal protection measures 🔗

Individual protection against mosquito bites remains fundamental to malaria prevention. Key measures include using insecticide-treated bed nets (especially LLINs), wearing protective clothing during evening and night hours, applying insect repellents containing DEET, and using mosquito screens on windows and doors. Since Anopheles mosquitoes feed from dusk until dawn, these measures are most critical during nighttime hours.

Vector control interventions 🔗

Integrated Vector Management (IVM) forms the core of India’s malaria control efforts. Indoor Residual Spraying (IRS) with approved insecticides targets adult mosquitoes resting on walls after blood meals. Source reduction through environmental management eliminates mosquito breeding sites. Larviciding with biological or chemical agents controls mosquito populations at the aquatic stage.

Community participation and health education 🔗

Community engagement is essential for sustainable malaria control. Detection and treatment of malaria is available at the community level through ASHAs (Accredited Social Health Activists), who provide diagnostic services using rapid diagnostic kits and treatment in remote areas. Health education campaigns promote awareness about malaria transmission, symptoms, and prevention measures.

Early diagnosis and treatment 🔗

Prompt diagnosis and appropriate treatment prevent disease progression and reduce transmission. The current strategy emphasises a “testing, treating, and tracking” approach with strengthened surveillance through the Integrated Health Information Platform (IHIP). Artemisinin-based combination therapy (ACT) is used for P. falciparum infections, while chloroquine remains effective for other species in most areas.

Role of nursing professionals 🔗

Community health nurses play a crucial role in malaria control through case identification and referral, health education at household and community levels, supporting vector control activities, and ensuring treatment adherence. Nurses working in endemic areas must maintain a high index of suspicion for malaria in febrile patients and understand the importance of complete treatment courses to prevent drug resistance.

What do you think? How can community health nurses better integrate malaria prevention education into their routine interactions with families in endemic areas? What innovative strategies could improve bed net usage in communities where uptake remains low?

References

1. https://www.ncbi.nlm.nih.gov/books/NBK8584/
2. https://www.ncbi.nlm.nih.gov/books/NBK1720/
3. https://en.wikipedia.org/wiki/Plasmodium_falciparum
4. https://pib.gov.in/PressReleasePage.aspx?PRID=2087878
5. https://dghs.gov.in/content/1364_3_NationalVectorBorneDiseaseControlProgramme.aspx
6. https://pubmed.ncbi.nlm.nih.gov/15462962/
7. https://pubmed.ncbi.nlm.nih.gov/3749959/